Herbochem unveils research on ashwagandha’s impact on mental health

The research underscores the adaptogenic, anti-stress, anti-anxiety, and antidepressant properties of Ashwagandha

Herbochem, a trailblazer in herbal and natural products with over 50 years of industry prowess, announced a breakthrough study on the mental soundness benefits of Ashwagandha. This significant study, published in the International Journal of Research in Medical Sciences, highlights the efficacy of Ashwagandha. As an ancient medicinal herb deeply rooted in traditional Ayurvedic practices, Ashwagandha (Withania somnifera) has been a cornerstone of holistic well-being in India for centuries. Recognised as an adaptogen, it plays a vital role in stress management and overall balance within the body. The research underscores the adaptogenic, anti-stress, anti-anxiety, and antidepressant properties of Ashwagandha. With mental health disorders on the rise globally, particularly during the COVID-19 pandemic, Ashwagandha emerges as a potent solution to alleviate symptoms such as depression, stress, anxiety, and sleep disorders.

In a head-to-head comparison, the study zeroes in on two Ashwagandha brands: Herbochem +91 (500mg capsules) and 600mg capsules from another notable brand. Renowned for its adaptogenic and antidepressant properties, Ashwagandha showcased remarkable efficacy in mitigating mental health symptoms. The research revealed compelling insights into the efficacy and safety of Ashwagandha 500mg capsules. Ashwagandha 500mg exhibited significantly higher reductions in perceived stress, Hamilton depression scale scores, and Beck’s anxiety inventory scores when compared to the control group. The study establishes that the optimal dosage of Ashwagandha 500mg demonstrated superior efficacy in reducing mental health symptoms compared to the Ashwagandha 600mg.

The study, a collaborative effort by renowned institutions including the Department of Biochemistry at Shivaji University, Kolhapur, Maharashtra, ViVforever Aesthetics Private Limited, Mumbai, Maharashtra, and the Critical Care Department at Vakratunda Hospital, Nashik, Maharashtra, delves into the global surge in mental health disorders, particularly during the COVID-19 pandemic. The study emphasises the prevalent symptoms of depression, stress, anxiety, and sleep disorders, underscoring the pressing need for effective solutions.

Read Previous

Smirnoff launches RTD Smirnoff Smash vodka soda

Read Next

AgroFresh takes steps to address industry’s most pressing challenges

Leave a Reply